Author

R. Tata

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Laleu· 1 shared C. Njanpa· 1 shared D. Dize· 1 shared F. F. Boyom· 1 shared J. Duffy· 1 shared L. Y. Tchokouaha· 1 shared M. B. Tchatat· 1 shared O. T. Bishop· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

B. Laleu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Rudimentary Structure-Activity-Relationship study of the MMV Pathogen Box compound MMV675968 (2,4-diaminoquinazoline) unveils novel inhibitors of Trypanosoma brucei brucei DHFR enzyme

D. Dize, R. Tata, R. Keumoe, R. T. Kouipou, M. B. Tchatat, C. Njanpa, V. C. Tchuenguia, L. Y. Tchokouaha, P. V. T. Fokou, B. Laleu, J. Duffy, O. T. Bishop, F. F. Boyom

This study identifies two potent analogs of MMV675968 that inhibit Trypanosoma brucei DHFR with higher potency and selectivity, showing potential as new antitrypanosomal drug candidates.

bioRxiv · May 20, 2022 · PreprintPharmacology & Toxicology